Proceedings: Statistical considerations in the planning and analysis of pharmacokinetic experiments.
作者信息
Westlake W J
出版信息
Acta Pharm Suec. 1974 Dec;11(6):632.
PMID:1136784
Abstract
摘要
相似文献
1
Proceedings: Statistical considerations in the planning and analysis of pharmacokinetic experiments.会议论文集：药代动力学实验设计与分析中的统计学考量
Acta Pharm Suec. 1974 Dec;11(6):632.
2
Identifiability: its role in design of pharmacokinetic experiments.可识别性：其在药代动力学实验设计中的作用。
IEEE Trans Biomed Eng. 1982 Jan;29(1):49-54. doi: 10.1109/TBME.1982.324963.
3
4
[The method of statistical moments and the integral model-independent parameters of pharmacokinetics].[统计矩方法与药代动力学的积分模型无关参数]
Farmakol Toksikol. 1986 Sep-Oct;49(5):118-27.
5
Mean residence time.平均停留时间。
Methods Find Exp Clin Pharmacol. 1986 May;8(5):309-12.
6
[Planning for Phase I in clinico-pharmacological research].[临床药理学研究中I期试验的规划]
Arzneimittelforschung. 1973 Nov;23(11):Suppl:1625-8.
7
Confidence intervals for pharmacokinetic parameters [proceedings].药代动力学参数的置信区间[会议论文集]
Br J Pharmacol. 1978 Mar;62(3):453P.
8
[Some fundamental concepts of pharmacokinetic practice].[药代动力学实践的一些基本概念]
Pharm Acta Helv. 1974;49(7-8):217-28.
9
Physiologic pharmacokinetic models: relevance, experience, and future trends.生理药代动力学模型：相关性、经验及未来趋势。
Drug Metab Rev. 1984;15(1-2):55-74. doi: 10.3109/03602538409015057.
10
Proceedings: A critical analysis of the "flip-flop" phenomenon in the two compartment pharmacokinetic model.论文集：两室药代动力学模型中“翻转”现象的批判性分析
J Pharm Pharmacol. 1975 Dec;27 Suppl?-2:71P.
Zotero 插件